×
Brainsway Share Holder Equity 2018-2025 | BWAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Brainsway share holder equity from 2018 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
View More
Brainsway Share Holder Equity 2018-2025 | BWAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Brainsway share holder equity from 2018 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$218.6B
Boston Scientific (BSX)
$157.1B
Stryker (SYK)
$151.4B
EssilorLuxottica (ESLOY)
$135B
Medtronic (MDT)
$118.4B
Lonza Group Ag (LZAGY)
$50B
Haleon (HLN)
$44.2B
ResMed (RMD)
$40.1B
GE HealthCare Technologies (GEHC)
$35.2B
Agilent Technologies (A)
$34.2B
Terumo (TRUMY)
$26B
Koninklijke Philips (PHG)
$24.9B
Insulet (PODD)
$20.2B
Zimmer Biomet Holdings (ZBH)
$19.2B
Baxter (BAX)
$14.8B
Smith & Nephew SNATS (SNN)
$13.8B
Sunny Optical Technology (SNPTF)
$10.4B
Demant (WILYY)
$8.6B
Bio-Rad Laboratories (BIO)
$7.1B
Lantheus Holdings (LNTH)
$4.9B
Perrigo (PRGO)
$3.9B
Prestige Consumer Healthcare (PBH)
$3.8B
Haemonetics (HAE)
$3.6B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
ICU Medical (ICUI)
$3.2B
LeMaitre Vascular (LMAT)
$1.8B
QuidelOrtho (QDEL)
$1.8B
AtriCure (ATRC)
$1.5B
Acuren (TIC)
$1.5B